1. Mortality risk increases with clustered ventricular arrhythmias in patients with implantable cardioverter-defibrillators;Elsokkari;J Am Coll Cardiol EP,2020
2. Cardiac resynchronization therapy reduces ventricular arrhythmias in primary but not secondary prophylactic implantable cardioverter defibrillator patients: insight from the Resynchronization in Ambulatory Heart Failure Trial;Sapp;Circ Arrhythm Electrophysiol,2017
3. Neurohormonal antagonists are preferred to an implantable cardioverter-defibrillator in preventing sudden death in heart failure;Packer;J Am Coll Cardiol HF,2019
4. Recent insights into mechanisms and clinical approaches to electrical storm;Elsokkari;Can J Cardiol,2022
5. Ventricular tachycardia burden and mortality: association or causality?;Samuel;Can J Cardiol,2022